Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues - Wikidata - awgldk - TriplyDB

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

http://www.wikidata.org/entity/Q28253419

about

Heavy marijuana users show increased serum apolipoprotein C-III levels: evidence from proteomic analyses Proteomics Research in Schizophrenia Urinary Biomarkers of Brain Diseases Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders?Altered functional protein networks in the prefrontal cortex and amygdala of victims of suicide Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach.Molecular substrates of schizophrenia: homeostatic signaling to connectivity Challenges for biomarker discovery in body fluids using SELDI-TOF-MS."Gestaltomics": Systems Biology Schemes for the Study of Neuropsychiatric Diseases.Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.The role of proteomics in depression research Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders.Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation APOA-I: a possible novel biomarker for metabolic side effects in first episode schizophrenia.ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype Apolipoproteins in the brain: implications for neurological and psychiatric disorders.Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia.Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.The Difference between Anxiolytic and Anxiogenic Effects Induced by Acute and Chronic Alcohol Exposure and Changes in Associative Learning and Memory Based on Color Preference and the Cause of Parkinson-Like Behaviors in Zebrafish.Two-Dimensional Differential Gel Electrophoresis to Identify Protein Biomarkers in Amniotic Fluid of Edwards Syndrome (Trisomy 18) Pregnancies.Dissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers.Specific alterations in plasma proteins during depressed, manic, and euthymic states of bipolar disorder.Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice The proteome of schizophrenia.The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders Proteome analysis of schizophrenia brain tissue.2D DIGE of the cerebrospinal fluid proteome in neurological diseases.Proteomic research in psychiatry.Quantitative proteomics for investigating psychiatric disorders.Proteomic approaches to unravel the complexity of schizophrenia.Potential biomarkers in psychiatry: focus on the cholesterol system.Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.HDL and cholesterol handling in the brain.Global research challenges and opportunities for mental health and substance-use disorders.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.Blood biomarker discovery in drug-free schizophrenia: the contributionof proteomics and multiplex immunoassays.Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers.

P2860

Q24654726-AF54ED65-D311-4F7D-A9F0-DCD1D84F381F Q26766821-B9D22C26-C46A-40CA-A8EF-8207CE8615D5 Q26769944-890BCA4B-7161-49BD-BC21-CCD2FAEDD624 Q27012892-0F70F1D3-941E-490A-91D9-8A4D41A7F05D Q28068871-B388FC41-5098-4618-AEB8-187A9A920C7E Q28083512-A6359052-F777-469B-8604-F506AFE46F27 Q28485508-B12E7140-B691-4CE7-815F-6BF3EF71FE5E Q30009461-30D37DC9-7BD2-4F56-88FE-A5A2E60AC794 Q30383611-D2787477-1121-41A0-9C31-A05D809C00F4 Q33520447-CEDAD5D4-61FF-4F9C-B0B3-BE6B60766311 Q33651168-CC8B3D5D-E754-4665-8B54-2D6BBC55452B Q33945211-FC21EC3A-F93C-4A3F-88DF-82CAE51F3A15 Q34130553-323CC8B5-6D74-4D6D-8AF2-F6CB68F791AC Q34214660-6B956166-8876-427E-91A6-17494C7500B4 Q34394932-A4262DB3-42B7-44EB-A0CD-64F3F4BE83B2 Q34414069-E02B49A0-3B06-4FB0-9BCC-1DEC4D2648A0 Q34419653-83D72E6E-E9BF-4711-8E3D-F6C88A48547D Q34680878-E94722B8-ED06-47D3-A100-F0BFDE4CF6D6 Q35162008-575129A8-9EDC-4CFC-9195-CC9258B63AE4 Q35603078-526B2CA0-EFDE-43A7-8279-124965DB4F13 Q35838566-198E9AA8-22BA-49DB-86A1-C5A35CAE731C Q35890658-8A15F9AC-1544-4D6F-8F30-06B1C7653087 Q36168593-930CEE05-D82C-411A-B9B5-541BD9843F10 Q36351715-BE0B180F-E883-4C66-8E51-FD19557B9C88 Q36637155-9B9D7149-D835-4A58-A915-AE106FDB29B6 Q36848272-029C95EB-5E0E-4FEB-8A12-11E27139C6C7 Q37056209-CB74CA39-B253-4660-A739-4729CB13F35C Q37682924-814791C1-01CA-4FCF-BAC7-1850226A32C1 Q37685107-5AF70935-C1AF-41B5-BDD8-0B4A9FACFA61 Q37689362-467F214C-1D75-4A1D-9319-12DBFE5776C0 Q37833588-17CC4F62-4C66-494C-A15B-7DB1B1863D80 Q37980246-66A33BF3-E6DE-4D13-B409-F81BB2D5BB52 Q37981261-6659AF7A-2BEC-4F7A-B0FF-B30A7B74B103 Q38027217-6239EF02-7A26-47DF-BC91-F05912F63DCD Q38218439-6881D1C1-925B-4000-A72C-6595D7B36FE1 Q38637216-18E29263-2416-4B31-9068-E57F3CB1A509 Q38805367-E1D37602-F4EA-4FDF-B27C-F0A14AD842C2 Q38807041-31C7CBB4-F63D-45BC-84F3-11068191E9C5 Q38844925-1A3559FE-D2B2-42B4-B3D0-F21373B818CE Q38939217-A4E89727-3386-444C-88D0-347AA832DD30

P2860

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

http://www.wikidata.org/entity/Q28253419

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Independent protein-profiling ...... , brain and peripheral tissues

@ast

Independent protein-profiling ...... , brain and peripheral tissues

@en

Independent protein-profiling ...... , brain and peripheral tissues

@nl

type

label

Independent protein-profiling ...... , brain and peripheral tissues

@ast

Independent protein-profiling ...... , brain and peripheral tissues

@en

Independent protein-profiling ...... , brain and peripheral tissues

@nl

prefLabel

Independent protein-profiling ...... , brain and peripheral tissues

@ast

Independent protein-profiling ...... , brain and peripheral tissues

@en

Independent protein-profiling ...... , brain and peripheral tissues

@nl

P1433

Q28253419-025CACB0-268F-40A3-840D-F47DE9EF0531

P1476

Q28253419-2EB46B51-767D-48AA-94C7-9F7B332C488A

P2093

Q28253419-0E37FFAD-565E-4F8C-9EB9-17004142C15E

Q28253419-22C342FB-D828-49B9-948B-7EE4DBE60BE6

Q28253419-46A8A988-839B-44E4-805D-D93A42002D7D

Q28253419-4A54B7D5-2FAE-4102-995B-132370A2A139

Q28253419-4DE08A5E-59AF-4CA1-AA20-6834C044C49A

Q28253419-4EF82359-BFC9-4444-9F3A-2DCD07719BC2

Q28253419-5F5DC643-B807-4E81-BDEA-B057EF7C1D11

Q28253419-88BD2DCA-F785-483A-BF02-95452F6EA57E

Q28253419-8E8B71C9-6059-4900-8E4E-7434A0C57C3D

Q28253419-AE349AF1-A1BE-483B-99E8-0F1DA80B1D3F

P2860

Q28253419-00BB0606-6770-4550-998A-11F08E2C6749

Q28253419-16CA3408-15FD-48C5-B735-A9B03401F35C

Q28253419-1B623876-F405-4ECD-9A03-121A93FA83D2

Q28253419-1CAA16DD-C002-4821-9BAF-702F22CADB5B

Q28253419-1DE60E7C-8CD4-4A1E-895C-1F28B3A121CE

Q28253419-35ADFE66-2234-4ED5-984E-2682A066C766

Q28253419-361D32F5-E423-4B11-BCA4-4CB86F21C498

Q28253419-44419E4D-8BA1-43EC-8CB8-79EA4E2EA130

Q28253419-4E0DCC7A-42E6-47E9-B863-59CE3FD29817

Q28253419-59884E39-0609-47DF-A6E7-5FDB22C5AEFE

P2888

Q28253419-DF52D2DA-E360-4D06-AB31-1591FF3F63AE

P304

Q28253419-7DF85DE8-70B2-4429-9CA2-6381276F8363

P31

Q28253419-BBFF599E-8A35-49C3-8CA0-09897562144E

P356

Q28253419-71686F69-4BEC-49E1-9563-5FEAE4C9E640

P407

Q28253419-C71FD58D-327F-46BC-BA6A-18C34CA4173F

P433

Q28253419-E2B3953B-2AB9-4203-ACC6-8397F919E58D

P478

Q28253419-949F49EF-B9FF-4F8C-B6B3-BF43BEC5EF2A

P50

Q28253419-90AD225F-3986-4B5E-A05E-E95436FDFF30

Q28253419-92373288-61BC-42D0-A7FD-976FDB3D6D01

P577

Q28253419-CD8E4B74-7E98-47CF-AEC3-94ED65A20072

P5875

Q28253419-AF61EE30-71C8-4859-BF01-ACEA66678D07

P698

Q28253419-EA6C5DE1-122F-4368-9C6C-4AE65BD5F336

P921

Q28253419-350BEBD6-72DA-4D1D-8309-60353BF8B2C0

Q28253419-3DDA4564-68CE-413B-8649-C6B02E1A1C49

P356

P1433

Molecular Psychiatry

P1476

Independent protein-profiling ...... , brain and peripheral tissues

@en

P2093

C W Gerth

http://www.w3.org/2001/XMLSchema#string

D Koethe

http://www.w3.org/2001/XMLSchema#string

D Oxley

http://www.w3.org/2001/XMLSchema#string

D Schreiber

http://www.w3.org/2001/XMLSchema#string

F M Leweke

http://www.w3.org/2001/XMLSchema#string

H E Lockstone

http://www.w3.org/2001/XMLSchema#string

J T-J Huang

http://www.w3.org/2001/XMLSchema#string

K Lilley

http://www.w3.org/2001/XMLSchema#string

L Wang

http://www.w3.org/2001/XMLSchema#string

M Wengenroth

http://www.w3.org/2001/XMLSchema#string

P2860

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia

Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease.

Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE).

The role of thyroid hormones in depression.

The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both?

Abnormalities in glucose regulation associated with mental illness and treatment.

The molecular genetics of schizophrenia: new findings promise new insights.

P2888

P304

1118-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.MP.4002108

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Matthew T. Wayland

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5906147

http://www.w3.org/2001/XMLSchema#string

P698

17938634

http://www.w3.org/2001/XMLSchema#string

P921